Anuj Gaggar

Compassionate Use of Remdesivir for Patients with Severe Covid-19

Jonathan Grein, Norio Ohmagari, Daniel D. Shin et al. · New England Journal of Medicine · 2020 · 2.9K citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +12

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19

Jason D. Goldman, David Chien Lye, David S.C. Hui et al. · New England Journal of Medicine · 2020 · 1.4K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19

Christoph D. Spinner, Robert Gottlieb, Gerard J. Criner et al. · JAMA · 2020 · 1.3K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +9

CD46 is a cellular receptor for group B adenoviruses

Anuj Gaggar, Dmitry M. Shayakhmetov, André Lieber · Nature Medicine · 2003 · 788 citations

Life Sciences, Cell Biology, Molecular Biology +12

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

Edward Gane, Wai Kay Seto, Henry Lik‐Yuen Chan et al. · ˜The œLancet. Gastroenterology & hepatology · 2016 · 546 citations

Pharmacy, Infectious Diseases, Pharmacology +12